Job title: Chief Development Officer
A seasoned biotech leader, Dr. Pestano heads up Development and Operations at Biodesix. His experience in laboratory and assay development for high complexity molecular diagnostics for oncology includes molecular and proteomic testing. Prior to joining Biodesix in 2012, Dr. Pestano led multidisciplinary teams in the development of tissue diagnostic tests, cancer vaccines and scientific software. He held senior positions in PharmaServices, R&D and Project Leadership at Ventana, a member of the Roche Group. Dr. Pestano is the co-inventor on multiple national and international patents for diagnostic tests. He has also fostered many collaborations in academia and industry as a part of new product development. Dr. Pestano received his Ph.D. training in Cell and Molecular Biology at The Graduate Center, City University of New York and conducted his post-doctoral training in cancer immunology at the Dana Farber Cancer Institute, Harvard Medical School.
Liquid Biopsy Coming of Age: Opportunities & Challenges for Impacting Patient Care 4:30 pm
• Over the last few years, liquid biopsy has rapidly gained traction and adoption as a complimentary technique to tissue biopsies. Concordance with FFPE tissues has been demonstrated and widely discussed as confidence in this blood-based technique grew • While progress has been made in the potential adoption of liquid biopsies in the clinic, such…Read more
day: Day One
Role of Multi-Modal Blood-Based Biomarkers for Profiling Tumor & Host Immune System in the Interpretation of Cancer Responses 4:00 pm
• Why it’s important to profile both tumor & immune blood-based biomarkers • Tumor Profiling: data & clinical uses for cell-free ddPCR & NGS assays • Immune Profiling: interpreting the immune response with mass spec & NGS • Bringing blood-based diagnostics from discovery to the clinicRead more
day: Day One